Davipharm steps up Vietnam’s pharma quality drive with European backing

Prime Minister Pham Minh Chinh and ministers met with Adamed Group in Warsaw, Poland, in January 2025.

Poland, the world’s 20th largest economy, driven by strong growth, is one of the key economies in the European Union. In this context, Adamed’s investment in Davipharm in Vietnam stands as

a prime example of effective international expansion by Polish capital. This initiative not only demonstrates the transfer of know-how and quality standards but also serves as a benchmark for other European companies, illustrating how international cooperation can drive local economic growth and strengthen Europe’s position on the global development map.

Adamed acquired stakes in Davipharm in 2017 and became its full owner in 2023. Today, Davipharm represents the largest Polish direct investment in Vietnam and has become one of the most dynamically developing companies in the country’s pharmaceutical sector. Its evolution underscores the increasing integration between Vietnam and Poland in trade, technology, and healthcare development, and highlights the growing importance of international partnerships in strengthening Vietnam’s long-term pharmaceutical capabilities.

Davipharm has been honored as one of the Top 10 Leading Brands in Vietnam in 2025.

Adamed has leveraged its scientific expertise, regulatory experience, and global technological know-how to support Davipharm’s transformation. This collaboration has enabled Davipharm to adopt international best practices and elevate its manufacturing to European standards.

Advancing industry standards through strategic investment

In 2021, Davipharm became one of the few Vietnamese pharmaceutical companies to obtain EU-GMP certification for non-sterile solid dosage forms, covering capsules, hard shells, and tablets. This milestone marked a major step forward in aligning the company’s operations with internationally recognised quality standards. In 2024, Davipharm became the first company in Vietnam and Southeast Asia, to obtain EU-GMP certification for its High Potent (HP) Zone for manufacturing high-quality oncology products.

In 2025, Davipharm was re-certified by the Philippines FDA, strengthening its export potential.

Adamed’s strategic engagement with Vietnam’s healthcare priorities was also reinforced during an official meeting in Warsaw in January 2025, where Vietnamese Prime Minister Phạm Minh Chinh, along with senior ministers, met with representatives of the Adamed Group. Discussions reinforced the shared commitment to building a more innovative and self-reliant pharmaceutical industry in Vietnam.

Inside Davipharm’s EU-GMP certified HP Zone.

A roadmap toward regional industry leadership

Guided by a long-term vision, Davipharm aims to become the number-one pharmaceutical exporter by 2033. The company is committed to producing high-quality medicines, backed by EU-GMP certification and scientific research. Its goal is to become the leading pharmaceutical exporter, beginning with Southeast Asia and gradually expanding into Europe and beyond.

Davipharm’s strategic initiatives for 2025-2028 focus on multiple areas. The company is establishing itself as a Southeast Asia export hub by registering in ASEAN countries, implementing license-out sales worldwide, and contributing to Vietnam’s economy by improving the trade balance. It is also expanding its factory with a new warehouse, an expanded production area, and a quality control laboratory to support its growing operations. Additionally, Davipharm is advancing high-tech production and export by developing pharmaceutical technologies that meet the strict regulatory standards of international markets.

As a socially responsible business, Davipharm has been a steadfast supporter of local communities. The company’s contributions range from providing high-quality medicines at reasonable prices nationwide to implementing education and healthcare programs for the people of Vietnam.

Three top students of ADAMED SmartUP 6th edition (Vietnam) joined the science summer camp in Poland in August 2025.

The company has been the first and only local pharmaceutical manufacturer to partner with the Ministry of Health in implementing a national program for early detection and prevention of non-communicable diseases (NCDs). Since its launch in 2021, the initiative known as Chăm Sóc Sức Khỏe Việt has reached over 9.5 million people through educational campaigns, provided training to more than 2,700 doctors, and facilitated screening and early diagnosis for nearly 26,000 individuals. This long-term commitment aligns closely with the government’s goal of reducing the burden of chronic diseases and improving access to preventative healthcare.

Davipharm also emphasises talent development and education. Through partnerships with universities, the company provides internships, factory tours, academic workshops, scholarships, trainee programs, and job opportunities, helping to cultivate a skilled workforce capable of supporting the next phase of Vietnam’s pharmaceutical growth.

Since 2019, the ADAMED SmartUP program has supported over 950 students from Vietnam-Poland High School, with winners participating in science summer camps in Poland.

Davipharm has been upgrading its infrastructure, equipment, and warehouses to boost production and improve product quality.

Strengthening reputation, sustainability, and global integration

Davipharm is likewise implementing ESG standards across its operations, securing its role as a reliable and desired partner in the global pharmaceutical supply chain. Its momentum has been reinforced by a series of recognitions that reflect its commitment to quality, workplace excellence, and sustainable business practices.

The company was honoured among the Top 10 Vietnam Leading Brands 2025 by the Asia Economic Research Institute in collaboration with the Vietnam Enterprise Development Science Union. It also earned multiple distinctions in the Vietnam Best Places to Work® 2025 rankings, including #4 in Pharmaceutical/ Medical Equipment/ Healthcare Services and #38 among Top 100 Best Places to Work for Medium Enterprises, Top 50 Best Employer of Choice® by Vietnam Student and #6 in Medical/ Pharmaceutical/ Nursing majors, as well as the Happiness at Work™ Certification with an 81% Happiness Index exceeding the industry average.

Looking forward, Davipharm is strengthening its regulatory alignment and certification efforts to expand its global footprint. In addition to EU-GMP and Philippine FDA certification, the company is actively working towards compliance with other standards to enable broader market access across Asia, the Middle East, and Eastern Europe.

This continued emphasis on quality and regulatory excellence reinforces the credibility of “Made in Vietnam” pharmaceuticals in international markets and supports Vietnam’s ambition to become a competitive regional hub for high-value manufacturing.

Davipharm’s mission to “respond to the key challenges of modern medicine” reflects a broader vision that extends beyond corporate growth. Through sustained investment in innovation, quality, and community impact, the company is making significant contributions to Vietnam’s healthcare outcomes and socioeconomic development. As Vietnam advances its healthcare priorities, Davipharm, leveraging Adamed’s global expertise, is well-positioned to play a significant role in shaping the country’s pharmaceutical landscape.

As we celebrate the 35th anniversary of EU–Vietnam diplomatic relations, Adamed and Davipharm are proud to contribute to this legacy of partnership and progress. Through sustained investment, innovation, and a shared vision for the future, we remain committed to supporting Vietnam’s healthcare development and strengthening the bonds between Europe and Vietnam for years to come.

Ninh Binh steps up actions to combat IUU fishing and promote sustainable fisheries The People’s Committee of Ninh Binh province has ordered intensified actions to combat illegal, unreported, and unregulated (IUU) fishing in line with the Prime Minister’s ...

Major retailer steps up delivery of aid to storm victims Saigon Co.op is rushing tens of tonnes of necessities and aid teams to regions in central and northern Vietnam following the devastation caused by recent ...